Peter Sankey
Impact in
- Oncology top 10%
- COVID-19 and healthcare impacts
- Cancer Immunotherapy and Biomarkers
- Global Cancer Incidence and Screening
- Colorectal Cancer Screening and Detection
-
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
Papers in
- Oncology 6
- Cancer Immunotherapy and Biomarkers 4
- COVID-19 and healthcare impacts 1
- PARP inhibition in cancer therapy 1
-
- Prostate Cancer Treatment and Research 3
- Prostate Cancer Diagnosis and Treatment 2
- Vasculitis and related conditions 1
- Co-authors
- Elnara Fazio‐Eynullayeva (1 shared paper)Christopher M. McNair (1 shared paper)Matvey B. Palchuk (1 shared paper)Jack London (1 shared paper)Debra Hannah Josephs (2 shared papers)Simon J. Crabb (2 shared papers)Rob Jones (2 shared papers)Mark David Linch (2 shared papers)
- Journals
- Annals of Oncology (3 papers)Journal of Clinical Oncology (1 paper)JCO Clinical Cancer Informatics (1 paper)Clinical and Translational Radiation Oncology (1 paper)European Journal of Cancer (1 paper)
- Partner nations
- United KingdomUnited StatesItaly
In The Last Decade
Peter Sankey
9 papers receiving 349 citations
Peers
Comparison fields: 5 of 37
- Oncology 230
- Pulmonary and Respiratory Medicine 43
- Surgery 47
- Modeling and Simulation 5
- Infectious Diseases 16
Countries citing papers authored by Peter Sankey
This map shows the geographic impact of Peter Sankey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Sankey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Sankey more than expected).
Fields of papers citing papers by Peter Sankey
This network shows the impact of papers produced by Peter Sankey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Sankey. The network helps show where Peter Sankey may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Sankey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 249 | |
| 2 | 2023 | 56 | |
| 3 | 2020 | 16 | |
| 4 | 2024 | 15 | |
| 5 | 2022 | 9 | |
| 6 | 2025 | 6 | |
| 7 | 2022 | 4 | |
| 8 | 2020 | 1 | |
| 9 | 2025 | 1 | |
| 10 | 2020 | 0 |
About Peter Sankey
Peter Sankey is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Surgery and Nuclear Energy and Engineering, having authored 10 papers that have together received 357 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (4 papers), Prostate Cancer Treatment and Research (3 papers), Prostate Cancer Diagnosis and Treatment (2 papers), COVID-19 and healthcare impacts (1 paper), Bladder and Urothelial Cancer Treatments (1 paper), PARP inhibition in cancer therapy (1 paper), Medical Imaging Techniques and Applications (1 paper) and Vasculitis and related conditions (1 paper). The work is most often cited by research in Oncology (230 citations), Pulmonary and Respiratory Medicine (43 citations), Surgery (47 citations), Modeling and Simulation (5 citations) and Infectious Diseases (16 citations). Peter Sankey has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Elnara Fazio‐Eynullayeva, Christopher M. McNair, Matvey B. Palchuk, Jack London, Debra Hannah Josephs, Simon J. Crabb, Rob Jones, Mark David Linch, Daniel Poon and Emma Hall. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, JCO Clinical Cancer Informatics, Clinical and Translational Radiation Oncology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.